UK markets closed
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • FTSE 250

    22,324.19
    -210.95 (-0.94%)
     
  • AIM

    1,229.80
    -11.57 (-0.93%)
     
  • GBP/EUR

    1.1636
    -0.0053 (-0.46%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • BTC-GBP

    26,037.79
    -1,501.80 (-5.45%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • DOW

    33,290.08
    -533.37 (-1.58%)
     
  • CRUDE OIL

    71.50
    +0.46 (+0.65%)
     
  • GOLD FUTURES

    1,763.90
    -10.90 (-0.61%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • HANG SENG

    28,801.27
    +242.68 (+0.85%)
     
  • DAX

    15,448.04
    -279.63 (-1.78%)
     
  • CAC 40

    6,569.16
    -97.10 (-1.46%)
     

Animal Health Market size Estimated at US$89,325.2 Million by 2031. Visiongain Research Inc.

·5-min read

Visiongain has published a new report on “Animal Health Market,2021-2031”. Forecasts By Animal Type {Production Animal (Poultry, Swine, Cattle, Sheep & Goats, Fish), Companion Animal (Dogs, Cats, Horses, Others)}; Product {Vaccines (Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Inactivated Vaccines, Others), Pharmaceuticals (Parasiticides, Anti-Infectives, Anti-Inflammatory, Analgesics, Others), Feed Additives (Nutritional, Medicinal), Diagnostics [Immunodiagnostics (ELISA Tests, Allergen-specific Immunodiagnostic Tests, Immunoassay Analyzers, Others), Molecular Diagnostics (Polymer Chain Reaction Tests, Microarrays, Others), Clinical Biochemistry, Hematology, Urinalysis, Others], Others}; Distribution Channel (Retail, E-Commerce, Hospital Pharmacy), End-Use (Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), PLUS COVID-19 Recovery Scenarios.

Visiongain’s animal health expert says: ‘The global animal health market is estimated to be valued at US$48,124.6million in 2020. The market is expected to reach US$66,117.6 million in 2026 from its previous value of US$50,603.0 million in 2021. We anticipate that the region will reach US$89,325.2 million in 2031’.

Download Exclusive Sample of Report @https://www.visiongain.com/report/animal-health-market-2021/#download_sampe_div

Which Factors are Fuelling Animal Health Industry Growth?

  • Growing Funding in Animal Healthcare Industry

  • Branded Generics Boosting Animal Health Market

  • Growing Incidence of Zoonotic Diseases

  • Rapid Technological Advancements

  • Growing Focus on Animal Health

Which Factors are RestrainingAnimal Health Industry Growth?

  • Lack of Standardization

  • Increasing Influx of Counterfeit Drugs

  • Rising Vaccine Storage Cost

Innovation in Pet Health to Fuel Animal Health Market Growth
The animal health sector is anticipated to evolve at a rapid pace. The veterinary health industry has diverse opportunities to implement new technologies. In veterinary clinics, for example, data generated can be uploaded to the internet for sharing with other clinics and researchers. This can allow for real-time monitoring of changes in disease prevalence. In addition, contact between vets and owners in real time about pet health concerns using mobile online technology is a significant area of development.

How the Animal Health Market report helps you.
In summary, our 410+ page report provides you with the following knowledge:

• Revenue forecasts to 2031 for Animal Health Market, with forecasts for Animal Type, Product, Distribution Channel, and End-Use, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2031 for 5 regional and 16 key national markets– See forecasts for the Animal Health market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Animal Health Market. Some of the company’s profiled in this report include Merck Animal Health, SeQuent (Alivira Animal Health Limited), Zoetis, Boehringer Ingelheim GmbH, Elanco, Ceva, Virbac, Vetiquinol S.A., AusDiagnostics Pty, Ltd., Agrolabo S.p.A, BioMérieux SA, Bio-X Diagnostics, Chembio Diagnostic Systems, Inc., Creative Diagnostics, Demedetic Diagnostics GmbH, DRG Diagnostics GmbH, Eurofins Technologies, EurolyserDiagnostica, Genesig (Primerdesign), Heska Corporation, IDEXX Laboratories, Inc., InBios International, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.

Get Detailed TOC @https://www.visiongain.com/report/animal-health-market-2021/#download_sampe_div

Asia Pacific to Witness Highest Growth Rate
Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing investments for strengthening the animal healthcare sector by government across economies of China and India. Over the years, animal husbandry in India has undergone magnificent changes thanks to the adoption of innovative technologies for the prevention and treatment of farm animals and their companions. There has been a fundamental change in the market philosophy to animal welfare firms, which has changed from medical to preventive to quality improvement, and now to comprehensive animal health services. The animal welfare sector has developed and driven animal husbandry to unprecedented heights of prominence through modern methods and paradigms.

Who are the key players in this market?

Some of the companies profiled in the report include Merck Animal Health, SeQuent (Alivira Animal Health Limited), Zoetis, Boehringer Ingelheim GmbH, Elanco, Ceva, Virbac, Vetiquinol S.A., AusDiagnostics Pty, Ltd., Agrolabo S.p.A, BioMérieux SA, Bio-X Diagnostics, Chembio Diagnostic Systems, Inc., Creative Diagnostics, Demedetic Diagnostics GmbH, DRG Diagnostics GmbH, Eurofins Technologies, EurolyserDiagnostica, Genesig (Primerdesign), Heska Corporation, IDEXX Laboratories, Inc., InBios International, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Find more research reports on the Animal Pharma Industry, please click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10 year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.

Contact:
Sara Peerun
Commercial Director
Visiongain Inc.
Tel: + 44 207 549 9987
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Email: sara.peerun@visiongain.com
Web: https://www.visiongain.com/
Follow Us: LinkedIn | Twitter
-
SOURCE Visiongain Limited.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting